Literature DB >> 24981453

The receptor for the complement C3a anaphylatoxin (C3aR) provides host protection against Listeria monocytogenes-induced apoptosis.

Stacey L Mueller-Ortiz1, John E Morales1, Rick A Wetsel2.   

Abstract

Listeria monocytogenes is a Gram-positive intracellular bacterium that is acquired through tainted food and may lead to systemic infection and possible death. Despite the importance of the innate immune system in fighting L. monocytogenes infection, little is known about the role of complement and its activation products, including the potent C3a anaphylatoxin. In a model of systemic L. monocytogenes infection, we show that mice lacking the receptor for C3a (C3aR(-/-)) are significantly more sensitive to infection compared with wild-type mice, as demonstrated by decreased survival, increased bacterial burden, and increased damage to their livers and spleens. The inability of the C3aR(-/-) mice to clear the bacterial infection was not caused by defective macrophages or by a reduction in cytokines/chemokines known to be critical in the host response to L. monocytogenes, including IFN-γ and TNF-α. Instead, TUNEL staining, together with Fas, active caspase-3, and Bcl-2 expression data, indicates that the increased susceptibility of C3aR(-/-) mice to L. monocytogenes infection was largely caused by increased L. monocytogenes-induced apoptosis of myeloid and lymphoid cells in the spleen that are required for ultimate clearance of L. monocytogenes, including neutrophils, macrophages, dendritic cells, and T cells. These findings reveal an unexpected function of C3a/C3aR signaling during the host immune response that suppresses Fas expression and caspase-3 activity while increasing Bcl-2 expression, thereby providing protection to both myeloid and lymphoid cells against L. monocytogenes-induced apoptosis.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24981453      PMCID: PMC4122265          DOI: 10.4049/jimmunol.1302787

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  63 in total

1.  Extracellular superoxide dismutase inhibits innate immune responses and clearance of an intracellular bacterial infection.

Authors:  Timothy J Break; Sujung Jun; Mohanalaxmi Indramohan; Karen D Carr; Amy N Sieve; Ladislav Dory; Rance E Berg
Journal:  J Immunol       Date:  2012-03-05       Impact factor: 5.422

2.  A role for the C3a anaphylatoxin receptor in the effector phase of asthma.

Authors:  A A Humbles; B Lu; C A Nilsson; C Lilly; E Israel; Y Fujiwara; N P Gerard; C Gerard
Journal:  Nature       Date:  2000-08-31       Impact factor: 49.962

Review 3.  Complement-triggered pathways orchestrate regenerative responses throughout phylogenesis.

Authors:  Dimitrios C Mastellos; Robert A Deangelis; John D Lambris
Journal:  Semin Immunol       Date:  2013-05-17       Impact factor: 11.130

4.  Receptor for complement peptide C3a: a therapeutic target for neonatal hypoxic-ischemic brain injury.

Authors:  Katarina Järlestedt; Catherine I Rousset; Anders Ståhlberg; Hana Sourkova; Alison L Atkins; Claire Thornton; Scott R Barnum; Rick A Wetsel; Mike Dragunow; Milos Pekny; Carina Mallard; Henrik Hagberg; Marcela Pekna
Journal:  FASEB J       Date:  2013-06-04       Impact factor: 5.191

5.  Specific immunity to Listeria monocytogenes in the absence of IFN gamma.

Authors:  J T Harty; M J Bevan
Journal:  Immunity       Date:  1995-07       Impact factor: 31.745

6.  Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation.

Authors:  M Kathryn Liszewski; Martin Kolev; Gaelle Le Friec; Marilyn Leung; Paula G Bertram; Antonella F Fara; Marta Subias; Matthew C Pickering; Christian Drouet; Seppo Meri; T Petteri Arstila; Pirkka T Pekkarinen; Margaret Ma; Andrew Cope; Thomas Reinheckel; Santiago Rodriguez de Cordoba; Behdad Afzali; John P Atkinson; Claudia Kemper
Journal:  Immunity       Date:  2013-12-05       Impact factor: 31.745

7.  Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells.

Authors:  Wing-hong Kwan; William van der Touw; Estela Paz-Artal; Ming O Li; Peter S Heeger
Journal:  J Exp Med       Date:  2013-02-04       Impact factor: 14.307

8.  Negative regulation of pulmonary Th17 responses by C3a anaphylatoxin during allergic inflammation in mice.

Authors:  Hoyong Lim; Young Uk Kim; Scott M Drouin; Stacey Mueller-Ortiz; Kyoungah Yun; Eva Morschl; Rick A Wetsel; Yeonseok Chung
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

9.  Complement anaphylatoxin C3a is a potent inducer of embryonic chick retina regeneration.

Authors:  Tracy Haynes; Agustin Luz-Madrigal; Edimara S Reis; Nancy P Echeverri Ruiz; Erika Grajales-Esquivel; Apostolia Tzekou; Panagiotis A Tsonis; John D Lambris; Katia Del Rio-Tsonis
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Absence of signaling into CD4⁺ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3⁺ regulatory T cells.

Authors:  Michael G Strainic; Ethan M Shevach; Fengqi An; Feng Lin; M Edward Medof
Journal:  Nat Immunol       Date:  2012-12-23       Impact factor: 25.606

View more
  17 in total

1.  The Complement Anaphylatoxins C5a and C3a Suppress IFN-β Production in Response to Listeria monocytogenes by Inhibition of the Cyclic Dinucleotide-Activated Cytosolic Surveillance Pathway.

Authors:  Stacey L Mueller-Ortiz; Daniel G Calame; Nancy Shenoi; Yi-Dong Li; Rick A Wetsel
Journal:  J Immunol       Date:  2017-03-08       Impact factor: 5.422

Review 2.  Innate and adaptive immunologic functions of complement in the host response to Listeria monocytogenes infection.

Authors:  Daniel G Calame; Stacey L Mueller-Ortiz; Rick A Wetsel
Journal:  Immunobiology       Date:  2016-07-16       Impact factor: 3.144

3.  Intracellular C3 Protects Human Airway Epithelial Cells from Stress-associated Cell Death.

Authors:  Hrishikesh S Kulkarni; Michelle L Elvington; Yi-Chieh Perng; M Kathryn Liszewski; Derek E Byers; Christopher Farkouh; Roger D Yusen; Deborah J Lenschow; Steven L Brody; John P Atkinson
Journal:  Am J Respir Cell Mol Biol       Date:  2019-02       Impact factor: 6.914

4.  The C5a anaphylatoxin receptor (C5aR1) protects against Listeria monocytogenes infection by inhibiting type 1 IFN expression.

Authors:  Daniel G Calame; Stacey L Mueller-Ortiz; John E Morales; Rick A Wetsel
Journal:  J Immunol       Date:  2014-10-08       Impact factor: 5.422

5.  Complement 5a Enhances Hepatic Metastases of Colon Cancer via Monocyte Chemoattractant Protein-1-mediated Inflammatory Cell Infiltration.

Authors:  Chunmei Piao; Lun Cai; Shulan Qiu; Lixin Jia; Wenchao Song; Jie Du
Journal:  J Biol Chem       Date:  2015-03-04       Impact factor: 5.157

6.  The Second Receptor for C5a, C5aR2, Is Detrimental to Mice during Systemic Infection with Listeria monocytogenes.

Authors:  Stacey L Mueller-Ortiz; Pooja Shivshankar; Rick A Wetsel
Journal:  J Immunol       Date:  2019-10-09       Impact factor: 5.422

7.  Brain microvascular endothelial cells exhibit lower activation of the alternative complement pathway than glomerular microvascular endothelial cells.

Authors:  Sarah E Sartain; Nancy A Turner; Joel L Moake
Journal:  J Biol Chem       Date:  2018-03-19       Impact factor: 5.157

Review 8.  Applying complement therapeutics to rare diseases.

Authors:  Edimara S Reis; Dimitrios C Mastellos; Despina Yancopoulou; Antonio M Risitano; Daniel Ricklin; John D Lambris
Journal:  Clin Immunol       Date:  2015-09-01       Impact factor: 3.969

Review 9.  More than a Pore: Nonlytic Antimicrobial Functions of Complement and Bacterial Strategies for Evasion.

Authors:  Elisabet Bjanes; Victor Nizet
Journal:  Microbiol Mol Biol Rev       Date:  2021-01-27       Impact factor: 11.056

10.  Intracellular Complement Component 3 Attenuated Ischemia-Reperfusion Injury in the Isolated Buffer-Perfused Mouse Heart and Is Associated With Improved Metabolic Homeostasis.

Authors:  M-K Torp; T Ranheim; C Schjalm; M Hjorth; C M Heiestad; K T Dalen; P H Nilsson; T E Mollnes; S E Pischke; E Lien; J Vaage; A Yndestad; K-O Stensløkken
Journal:  Front Immunol       Date:  2022-04-01       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.